Hundreds of thousands of dollars worth of fake weight loss drugs were discovered during inspections and seized by Cincinnati ...

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on ...

Most telling though, the results that show that the overall obesity rate in the U.S. has not changed significantly in a ...

Washington — Lawmakers will question the maker of popular weight loss drugs Ozempic and Wegovy during a Senate committee hearing on Tuesday focused on what Sen. Bernie Sanders has called “ ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit down with lawmakers and pharmacy ...

Leading pharmacy benefit managers are reportedly willing to expand coverage for Novo Nordisk’s (NVO) popular diabetes and ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight ...